Next Article in Journal
The Role of Kinase Modulators in Cellular Senescence for Use in Cancer Treatment
Next Article in Special Issue
Function Oriented Molecular Design: Dendrimers as Novel Antimicrobials
Previous Article in Journal
Biosynthesis of Silver Nanoparticles on Orthodontic Elastomeric Modules: Evaluation of Mechanical and Antibacterial Properties
Previous Article in Special Issue
Dendrimers as Nanocarriers for Nucleic Acid and Drug Delivery in Cancer Therapy
Article Menu
Issue 9 (September) cover image

Export Article

Open AccessReview
Molecules 2017, 22(9), 1350;

Radiolabeled Dendrimers for Nuclear Medicine Applications

Department of Nuclear Medicine, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China
Basic Medical College, Ningxia Medical University, Yinchuan 750004, Ningxia, China
Author to whom correspondence should be addressed.
Received: 13 July 2017 / Revised: 10 August 2017 / Accepted: 10 August 2017 / Published: 25 August 2017
(This article belongs to the Special Issue Dendrimers in Medicine)
Full-Text   |   PDF [7281 KB, uploaded 25 August 2017]   |  


Recent advances in nuclear medicine have explored nanoscale carriers for targeted delivery of various radionuclides in specific manners to improve the effect of diagnosis and therapy of diseases. Due to the unique molecular architecture allowing facile attachment of targeting ligands and radionuclides, dendrimers provide versatile platforms in this filed to build abundant multifunctional radiolabeled nanoparticles for nuclear medicine applications. This review gives special focus to recent advances in dendrimer-based nuclear medicine agents for the imaging and treatment of cancer, cardiovascular and other diseases. Radiolabeling strategies for different radionuclides and several challenges involved in clinical translation of radiolabeled dendrimers are extensively discussed. View Full-Text
Keywords: dendrimers; nuclear medicine; PET; SPECT; radionuclide therapy; radiolabeling dendrimers; nuclear medicine; PET; SPECT; radionuclide therapy; radiolabeling

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Share & Cite This Article

MDPI and ACS Style

Zhao, L.; Zhu, M.; Li, Y.; Xing, Y.; Zhao, J. Radiolabeled Dendrimers for Nuclear Medicine Applications. Molecules 2017, 22, 1350.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics



[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top